INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/04/2026
Voltar para busca
Dado oficial do USPTO
EDVINCE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
56
Atualização mais recente
09/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
06/04/2017
Data de registro
22/01/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/08/2025
Última transação
09/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
SE-223 81 Lund, SE
Examinador
KAJUBI, ELIZABETH N
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Edvince AB
Representantes
Julie A. Greenberg Fishman Stewart PLLC
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Preparations for pharmaceutical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); preparations for medical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); diagnostic preparations for medical purposes for the treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia (DCI); chemical reagents for medical purposes; preparations for analysis for medical purposes, namely, for the treatment of ischemic disorders and diseases, stroke and subarachnoid hemorrhage and delayed cerebral ischemia (DCI)
Classe 42
Scientific and technological services, namely, scientific research, in the field of developing methods for the treatment, prevention and alleviation of stroke; industrial analysis and research in the field of development methods for treatment, prevention and alleviation of ischemic disorders and diseases, for the treatment, prevention and alleviation of stroke, for the treatment, prevention and alleviation of subarachnoid hemorrhage and delayed cerebral ischemia; basic research and clinical research in the field of development of medicaments
Publicações
Histórico de despachos e eventos da marca no USPTO.
56 publicações encontradas
C71T
CANCELLED SECTION 71
08/08/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/11/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
22/01/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/07/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/07/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
31/05/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
15/05/2019
FIMP
FINAL DISPOSITION PROCESSED
15/05/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/04/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/01/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/01/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
22/01/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/11/2018
PUBO
PUBLISHED FOR OPPOSITION
06/11/2018
GPNX
NOTIFICATION PROCESSED BY IB
02/11/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/10/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/10/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/10/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/09/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
27/09/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/09/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
27/09/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/09/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
17/09/2018
GNRT
NON-FINAL ACTION E-MAILED
17/09/2018
CNRT
NON-FINAL ACTION WRITTEN
17/09/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/09/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/08/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/08/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
30/08/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/08/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/08/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/08/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
28/08/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
16/04/2018
GNFR
FINAL REFUSAL E-MAILED
16/04/2018
CNFR
FINAL REFUSAL WRITTEN
16/04/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/03/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/03/2018
ALIE
ASSIGNED TO LIE
18/03/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/03/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/02/2018
RFNT
REFUSAL PROCESSED BY IB
29/10/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/09/2017
RFRR
REFUSAL PROCESSED BY MPU
20/09/2017
MAFR
APPLICATION FILING RECEIPT MAILED
15/09/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/09/2017
CNRT
NON-FINAL ACTION WRITTEN
13/09/2017
DOCK
ASSIGNED TO EXAMINER
11/09/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/09/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EDVINCE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.